Clinical Trial Update: Safety and Pharmacokinetic Study of EO9(Intravesical Instillation) [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetic study of EO9 administered via intravesical instillation for bladder cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• EO9

Snippet

Sponsor: Handok Inc. | Conditions: Bladder Cancer | Phase 1 | Status: COMPLETED